Modulating the gut-reproductive tract axis: microbial influence on gynaecological cancer pathogenesis and treatment.

Distinct alterations in gut microbiota, including reduced diversity and dysbiosis-associated taxa, are linked to ovarian, endometrial, and cervical cancers in patients.

• Why it matters: Understanding how microbiota influences reproductive tract cancers is crucial because it may reveal new biomarkers and therapeutic targets to improve patient outcomes.
• What they did: The study reviews evidence from patient cohorts and mechanisms involving gut-derived metabolites and microbial translocation affecting immune responses and oestrogen metabolism, with implications for therapy response.
• The result: Targeting the microbiota through dietary interventions, probiotics, or faecal microbiota transplantation shows potential to enhance treatment efficacy, though most applications are still investigational.